UK Markets closed

Hutchison China MediTech Limited (HCM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.17-0.48 (-2.44%)
At close: 04:00PM EST
19.50 +0.33 (+1.72%)
After hours: 05:26PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 328.40
52-week low 37.39
50-day moving average 315.41
200-day moving average 312.37

Share statistics

Avg vol (3-month) 3622.27k
Avg vol (10-day) 3382.16k
Shares outstanding 5172.96M
Implied shares outstanding 6N/A
Float 888.02M
% held by insiders 10.41%
% held by institutions 129.87%
Shares short (13 Oct 2022) 42.42M
Short ratio (13 Oct 2022) 45.87
Short % of float (13 Oct 2022) 4N/A
Short % of shares outstanding (13 Oct 2022) 41.40%
Shares short (prior month 14 Sept 2022) 41.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 329 May 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin -63.65%
Operating margin (ttm)-95.14%

Management effectiveness

Return on assets (ttm)-19.32%
Return on equity (ttm)-24.72%

Income statement

Revenue (ttm)400.81M
Revenue per share (ttm)2.35
Quarterly revenue growth (yoy)33.30%
Gross profit (ttm)-201.19M
EBITDA -373.29M
Net income avi to common (ttm)-255.11M
Diluted EPS (ttm)-0.90
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)829.71M
Total cash per share (mrq)4.91
Total debt (mrq)418k
Total debt/equity (mrq)0.05
Current ratio (mrq)3.18
Book value per share (mrq)3.34

Cash flow statement

Operating cash flow (ttm)-222.76M
Levered free cash flow (ttm)-161.87M